122 related articles for article (PubMed ID: 30273571)
1. Prognostic Significance of c-MYC Amplification in Esophageal Squamous Cell Carcinoma.
Huang J; Jiang D; Zhu T; Wang Y; Wang H; Wang Q; Tan L; Zhu H; Yao J; Hou Y
Ann Thorac Surg; 2019 Feb; 107(2):436-443. PubMed ID: 30273571
[TBL] [Abstract][Full Text] [Related]
2. Prognostic implications of
Kwon D; Yun JY; Keam B; Kim YT; Jeon YK
World J Gastroenterol; 2016 Nov; 22(44):9803-9812. PubMed ID: 27956804
[TBL] [Abstract][Full Text] [Related]
3. Increased MET gene copy number negatively affects the survival of esophageal squamous cell carcinoma patients.
Wang Y; Jiang Z; Xu C; Wang H; Tan L; Su J; Wang X; Jiang D; Hou Y; Song Q
BMC Cancer; 2019 Mar; 19(1):240. PubMed ID: 30885149
[TBL] [Abstract][Full Text] [Related]
4. Poor prognostic impact of FGF4 amplification in patients with esophageal squamous cell carcinoma.
Huang J; Song Q; Wang H; Wang H; Xu C; Wang X; Jiang Z; Wang Y; Xu Y; Su J; Zeng H; Tan L; Zhu H; Jiang D; Hou Y
Hum Pathol; 2018 Oct; 80():210-218. PubMed ID: 29936056
[TBL] [Abstract][Full Text] [Related]
5. Independent prognostic role of PD-L1expression in patients with esophageal squamous cell carcinoma.
Jiang D; Song Q; Wang H; Huang J; Wang H; Hou J; Li X; Xu Y; Sujie A; Zeng H; Tan L; Hou Y
Oncotarget; 2017 Jan; 8(5):8315-8329. PubMed ID: 28039448
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of CDK6 amplification in esophageal squamous cell carcinoma.
Liu K; Lu H; Jiang D; Guan Y; Xu H; Sun Q; Jiang Q; Zheng J; Chen H; Zhang F; Luo R; Huang Y; Xu J; Hou Y
Cancer Treat Res Commun; 2023; 35():100698. PubMed ID: 37023643
[TBL] [Abstract][Full Text] [Related]
7. PIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinoma.
Kim HS; Lee SE; Bae YS; Kim DJ; Lee CG; Hur J; Chung H; Park JC; Shin SK; Lee SK; Lee YC; Kim HR; Shim YM; Jewell SS; Kim H; Choi YL; Cho BC
Oncotarget; 2016 May; 7(21):30691-701. PubMed ID: 27095573
[TBL] [Abstract][Full Text] [Related]
8. YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma.
Dai H; Shao YW; Tong X; Wu X; Pang J; Feng A; Yang Z
Cancer Med; 2020 Mar; 9(5):1628-1637. PubMed ID: 31851786
[TBL] [Abstract][Full Text] [Related]
9. The prognostic role of c-MYC amplification in schistosomiasis-associated colorectal cancer.
Pan W; Wang W; Huang J; Lu K; Huang S; Jiang D; Bu D; Liu J; Jing H; Yao J; Hou Y
Jpn J Clin Oncol; 2020 Apr; 50(4):446-455. PubMed ID: 32297641
[TBL] [Abstract][Full Text] [Related]
10. Amplification of the telomerase RNA component gene as a new genetic marker for disease progression and prognosis in esophageal squamous cell carcinoma.
Wang JD; Ma J; Wang FY; Peng LB; Wang X; Shi SS; Ma HH; Lu ZF; Lu GM; Zhou XJ
Dis Esophagus; 2013; 26(7):737-45. PubMed ID: 23317107
[TBL] [Abstract][Full Text] [Related]
11. [Survival and the value of adjuvant chemotherapy in esophageal squamous cell carcinoma patients with lymphatic metastasis].
Qi Z; Wang YX; Yang Q; Li J; Yao JF; He M
Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):628-633. PubMed ID: 28835088
[No Abstract] [Full Text] [Related]
12. Mouse double minute 2 amplification in oesophageal squamous cell carcinoma is associated with better outcome.
Jiang D; Chen L; Huang J; Wang H; Song Q; Shi P; Wang H; Hou Y
Histopathology; 2020 Dec; 77(6):963-973. PubMed ID: 32652667
[TBL] [Abstract][Full Text] [Related]
13. Elevated expression of CCAT2 is associated with poor prognosis in esophageal squamous cell carcinoma.
Zhang X; Xu Y; He C; Guo X; Zhang J; He C; Zhang L; Kong M; Chen B; Zhu C
J Surg Oncol; 2015 Jun; 111(7):834-9. PubMed ID: 25919911
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of CCND1 amplification/overexpression in smoking patients with esophageal squamous cell carcinoma.
Jiang D; Song Q; Zhang F; Xu C; Li X; Zeng H; Su J; Huang J; Xu Y; Lu S; Hou Y
Cancer Genet; 2023 Nov; 278-279():1-8. PubMed ID: 37556965
[TBL] [Abstract][Full Text] [Related]
15. A Novel Three-Gene Model Predicts Prognosis and Therapeutic Sensitivity in Esophageal Squamous Cell Carcinoma.
Zeng FM; He JZ; Wang SH; Liu DK; Xu XE; Wu JY; Li EM; Xu LY
Biomed Res Int; 2019; 2019():9828637. PubMed ID: 31886273
[TBL] [Abstract][Full Text] [Related]
16. High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.
He LR; Liu MZ; Li BK; Jia WH; Zhang Y; Liao YJ; Chen YC; Zhang LJ; Guan XY; Zeng YX; Kung HF; Xie D
Int J Cancer; 2010 Jul; 127(1):138-47. PubMed ID: 19904743
[TBL] [Abstract][Full Text] [Related]
17. EGFR and TTF-1 gene amplification in surgically resected lung adenocarcinomas: clinicopathologic significance and effect on response to EGFR-tyrosine kinase inhibitors in recurred cases.
Lee JS; Kim HR; Lee CY; Shin M; Shim HS
Ann Surg Oncol; 2013 Sep; 20(9):3015-22. PubMed ID: 23525704
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of Ku80 in pT2N0M0 esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy.
Wang S; Wang Z; Liu X; Yang Y; Shi M; Sun Z
Tumour Biol; 2015 Aug; 36(8):6181-9. PubMed ID: 25758053
[TBL] [Abstract][Full Text] [Related]
19. [Patterns of recurrence in patients with stage pT3N0M0 thoracic esophageal squamous cell carcinoma after two-field esophagectomy].
Wang Y; Wang L; Yang Q; Li J; He M; Yao J; Qi Z; Li B; Qiao X
Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):48-54. PubMed ID: 26796807
[TBL] [Abstract][Full Text] [Related]
20. Expression and clinical significance of REPS2 in human esophageal squamous cell carcinoma.
Zhang H; Duan CJ; Zhang H; Cheng YD; Zhang CF
Asian Pac J Cancer Prev; 2013; 14(5):2851-7. PubMed ID: 23803043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
